No Data
No Data
Express News | Vigil Neuroscience- Files Prospectus to Offer & Resale, From Time to Time, of up to 5.4 Mln Shares of Common Stock by Selling Stockholder
H.C. Wainwright Maintains Vigil Neuroscience(VIGL.US) With Buy Rating, Cuts Target Price to $14
Vigil Neuroscience Is Maintained at Buy by HC Wainwright & Co.
Vigil Neuroscience Price Target Cut to $14.00/Share From $17.00 by HC Wainwright & Co.
Vigil Neuroscience Analyst Ratings
Vigil Neuroscience Price Target Lowered to $13 From $24 at Wedbush